DSGN   $5.86  3.90% Market Closed After Close 5.86 0.0

Design Therapeutics Inc
Total Cash 261.02M
totalCashPerShare 4.61
EBITDA -62.82M
Total Debt 2.70M
quickRatio 41.041
currentRatio 41.42
Total Revenue
debtToEquity 1.035
Revenue/Share
ROA -0.13632
ROE -0.18110001
grossProfits
freeCashflow -33.75M
operatingCashflow -51.03M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 55.36M
forwardPE -4.769231
floatShares 25.24M
sharesOutstanding 56.62M
sharesShort 2.19M
sharesShortPriorMonth 3.56M
dateShortInterest
sharesPercentSharesOut 0.04%
heldPercentInsiders 0.36%
heldPercentInstitutions 0.56%
Short Ratio help_outline 10.84%
shortPercentOfFloat 0.09%
impliedSharesOutstanding
bookValue 4.614
Price To Book help_outline 1.21
earningsQuarterlyGrowth
netIncomeToCommon -50.53M
trailingEps -0.90%
forwardEps -1.17%
enterpriseToEbitda -0.88
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.24 3Q 2024
institutionsCount 128
lastUpdated Sept. 16, 2024, 8:18 p.m.